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1. INTRODUCTION 
1.1. Cre/loxP-mediated site-specific recombination (SSR) 
Site-specific recombination (SSR) is a type of nonhomologous recombination that includes cleavage and 
rejoining of DNA strands. The recombination takes place only between specific sequences on DNA and is 
assisted by site-specific recombinases (Akopian and Stark, 2005; Snyder and Champness, 2007). These 
recombinases recognize specific DNA sites, cleave DNA backbone, exchange DNA material placed in 
between the sites and ligate the end products (Kolb, 2002).  
SSR serves a wide range of purposes such as resolution of bacterial chromosome and plasmid dimers, 
integration of phages into bacterial chromosomes, resolution of cointegrates formed during replicative 
transposition and assembly of mammalian antibody genes during B-cell maturation (Snyder and 
Champness, 2007; Kolb, 2002). The diverse potential of biological functions carried out by site-specific 
recombinases has been utilized in various genome engineering applications for decades. These include 
conditional mutagenesis (Gu et al., 1994; Kuhn et al., 1995; Logie and Stewart, 1995), removal of selectable 
genes (Gu et al., 1993), gene expression switches (O’Gorman et al., 1991; Lakso et al., 1992; Angrand et 
al., 1998), recombinase-mediated cassette exchange (Schlake and Bode, 1994; Baer and Bode, 2001; 
Wallace et al., 2007), lineage tracing (Awatramani et al., 2003) and chromosomal translocations (Smith et 
al., 1995; Herault et al., 1998; Buchholz et al., 2000; Collins et al., 2000; Liu et al., 2002). 
Based on the catalytic mechanism, site-specific recombinases can be divided into two classes: tyrosine 
(EC 2.7.7.) and serine recombinases (EC 3.1.22.) (Grindley et al., 2006). In genome engineering, the former 
class is used much more often. Some prominent members of the tyrosine recombinase family include Cre 
recombinase from phage P1, FLP recombinase from the yeast 2-micron plasmid, λ integrase from phage λ 
and XerCD from E. coli chromosome. The most widely used of the tyrosine recombinases, at least in 
genome engineering, is the Cre recombinase (Kolb, 2002). Cre's target sites, called loxP, are 13 bp inverted 
repeats (IRs) separated by a nonpalindromic 8 bp central spacer (Anastassiadis et al., 2010), (Figure 1a). 
One Cre monomer binds to each 13 bp IR and recombination occurs when two Cre dimers bound to two 
full loxP sites contact each other after a random collision, forming a tetramer synaptic complex (Ringrose 
et al., 1998). Since the 8 bp spacer is nonpalindromic, loxP sites are often represented by an arrowhead 
indicating the spacer direction (Anastassiadis et al., 2010). The spacer is critical for recombination as it is 
the site of the nucleophilic attack performed by Cre's active-site tyrosine residue, which results in a covalent 
phosphotyrosyl intermediate. The recombination mechanism of Cre and other tyrosine recombinases 
includes two rounds of single-strand cleavages, one per round on each DNA helix. These two events are 
connected via strand exchange leading to the so-called Holliday junction formation and isomerization which 
2 
 
enables resolution of the junction necessary for the second round of cleavage to occur (Grainge and 
Jayaram, 1999), (Figure 2). 
Depending on whether loxP sites are located on the same or different DNA molecules and on the orientation 
of the spacers, there are several possible outcomes of Cre-mediated recombination: excision, integration, 
inversion and translocation. Since Cre-mediated recombination is inherently reversible and loxP sites are 
more likely to come into close contact if they are located on the same DNA molecule, excision is favored 
over insertion. Inversions and translocations, generally speaking, occur equally likely in both forward and 
reverse direction (reviewed in Branda and Dymecki, 2004), (Figure 1b). 
There are several reasons for Cre's ubiquitous use in genome engineering. Firstly, it does not require ATP 
(Kolb, 2002) or any accessory proteins (Warren et al., 2008). Secondly, its small size (38 kDa) and the 
simplicity of loxP sites allow for easy genome manipulation. Thirdly, its single-strand intermediate 
mechanism avoids creation of side products such as hairpins and three-way junctions (Grindley, 2006) and 
complications caused by unresolved double-strand breaks. Furthermore, Cre works efficiently in all 
organisms tested so far, from prokaryotes to mammals (Anastassiadis et al., 2010). Finally, kinetic 
comparisons with another commonly used tyrosine recombinase, FLP, have shown that Cre has unusually 
high affinity towards its target site and shows high efficiency of substrate excision even at lower 
concentrations (Ringrose et al., 1998; Anastassiadis et al., 2009). However, the Cre-loxP system is not 
without its drawbacks. Inherent reversibility of Cre-mediated recombination, particularly pronounced when 
Cre is used for insertion rather than excision, and binding to cryptic loxP sites may cause side effects such 
as regeneration of the substrate site or unintended gene modifications, respectively. The reversibility 
problem has been tackled by development of mutant loxP sites, for example lox66/lox71, that enable 
unidirectionality, albeit at lower recombination efficiency than the wild-type loxP (Oberdoerffer et al., 
2003). If it is essential to avoid reversibility, large serine recombinases can be used instead of Cre 
(Anastassiadis et al., 2009). 
Diverse applications require diverse recombinases. Decades of SSR application development have yielded 
a wide range of Cre and loxP variants, but also identification of other recombinases and their recognition 
sites. Examples of loxP mutants include the aforementioned lox66/lox71 pair as well as lox2272 and 
lox5171, which are useful because they interact with each other but not with loxP. This means they can be 
used when several lox sites are being introduced in tandem and cross-reactions are undesirable (Araki et 
al., 1997; Lee and Salto, 1998). Other SSR proteins and their recognition sites have been identified and 
developed, such as Dre/Rox (Sauer and McDermott, 2004; Anastassiadis et al., 2009) and Vika/Vox 
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(Karimova et al., 2013). FLP recombinase has been temperature-optimized (FLPe) (Buchholz et al., 1998) 
and codon-optimized for use in mice (FLPo) (Raymond and Soriano, 2007). 
One of the most important improvements of Cre/loxP system came via Cre inducibility, which enabled 
spatial and temporal control of Cre activity (Feil et al., 2009). Cre was fused to the mutated hormone-
binding domain of the estrogen receptor, creating a fusion protein called CreER (Feil et al., 1996; Feil et 
al., 1997; Metzger et al., 1995; Zhang et al., 1996). The most successful version of this fusion protein is 
called CreERT2 (Feil et al., 2009). The estrogen receptor is retained in the cytoplasm until the 
administration of estrogen changes its conformation and shuttles it into the nucleus. 4-OHT (4-
hydroxytamoxifen) is usually used in Cre inducibility experiments instead of estrogen due to its more than 
100-fold increased affinity for the estrogen receptor proteins (Kuhl, 2005). 
 
Figure 1. A) The architecture of the loxP site, with the Cre-binding sites indicated in black and the spacer indicated 
in red. B) Possible outcomes of Cre/loxP-mediated recombination. Beige arrowheads represent spacer orientation and 
the thickness of the black arrows represents the directionality of recombination events. Adapted from Baker, 2015. 
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Figure 2. Mechanism of tyrosine recombinase-mediated SSR.  
C and C' represent cleaving subunits; NC and NC' represent non-cleaving subunits. The details of the mechanism are 
explained in the text. Adapted from Abi-Ghanem et al., 2015. 
1.2.  Mouse embryonic stem cells (mESCs) 
Owing to its great genetic similarity with humans, its small size and the speed of reproduction, mouse has 
become the favorite model organism in biomedicine. Advancements in the ability to manipulate mouse 
embryos and culture its embryonic stem cells concomitant with the ever more precise genetic engineering 
tools have fostered great efforts in investigation of molecular genetics of mammalian early development. 
Mouse embryos start developing through rounds of cell divisions producing first a ball-like 8-cell structure 
called a morula and subsequently a hollow sphere called a blastocyst. The outer layer of the blastocyst, 
termed trophoectoderm, contributes to formation of extraembryonic tissues like amniotic sac and the 
placenta, so called because they form no part of adult mammals. The inner cell mass of the blastocyst, on 
the other hand, gives rise to embryo proper. The cells of the inner cell mass are initially totipotent, ie. they 
can give rise to any tissue of the adult organism. A particularly interesting property of the inner cell mass 
is that it can be isolated and proliferated indefinitely in culture without losing its totipotency, producing 
embryonic stem cells (ESCs). The huge interest in advancement of ESC manipulation and research on their 
biological peculiarities is a result of their promising applications in tissue and organ repair as well as the 
ease and precision with which they can be genetically manipulated and ultimately produce a modified gene 
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of interest in a whole mouse due to their totipotency. The ease of genetic manipulation refers to their high 
transfection efficiency and their ability to incorporate foreign DNA into desirable genomic loci at 
reasonable frequencies as well as the variety of genetic engineering tools (eg. clustered regularly 
interspaced short palindromic repeats ‒ CRISPR-associated protein 9 method, abbreviated as CRISPR-
Cas9, SSR etc.) which are routinely applied on them. 
Mouse embryonic stem cells (mESCs) are derived from the inner cell mass of blastocysts at early stage of 
embryogenesis, from 3.5 days old pre-implantation embryos (Marin, 1981). Like other stem cells, mESCs 
can be cultured in vitro longer than most cell types due to their immortality and ability to retain their 
developmental potential even after prolonged clonal expansion. mESC culture requires addition of 
pluripotency-maintaining supplements, such as the leukemia inhibitory factor (LIF; Furue et al, 2005) or 
inhibitor combinations (glycogen synthase kinase-3 inhibitor CT99021 and ERK signal cascade inhibitor 
PD184352; Ying et al., 2008). Depending on the desired robustness of pluripotency maintenance and the 
type of mESCs used, a feeder layer of inactivated mouse embryonic fibroblasts is sometimes used (reviewed 
in Llames et al., 2015). Several mESC cell lines are in common use. They are derived either from the 129 
mouse strain (Downing and Battey, 2004; Simpson et al, 1997) or from C57BL/6J and C57BL/6N mouse 
strains (Seong et al., 2004; Keskintepe et al., 2007; Hansen et al., 2008). 129 derivatives E14, R1, D3 and 
J1 are used because of their robustness in cell culture and higher germline transmission rates. On the other 
hand, C57BL/6 strain is most commonly used as a reference for immunological, neurobiological, behavioral 
and physiological studies in mice (Bouabe and Okkenhaug, 2013). 
1.3.  Gene targeting in mESCs 
DNA sequences can be introduced into genomes either randomly (eg. by using viruses that stably integrate 
into a genome) (Jaenisch, 1976) or precisely (eg. by providing a template for homologous recombination 
(HR)). Gene targeting is a technique used for inserting DNA sequences into precise loci in the genome, 
usually gene bodies, using HR (Doetschman T et al., 1987; Thomas and Capecchi, 1987; Thompson et al., 
1989). Gene targeting can be used to delete or insert mutations into genes to determine their function by 
the loss-of-function approach; introduce human genes into murine genomes to establish models to study 
human diseases and human-specific genes; introduce pathogen genes or genomes to examine their 
contribution to pathogenesis; introduce reporter genes to monitor expression of genes of interest (reviewed 
in Bouabe and Okkenhaug, 2013). 
Gene targeting is achieved by introduction of a targeting construct (TC) into mESCs by transfecting the 
DNA into the cells (Hall at al., 2010). A TC is usually composed of a 5'-homology arm (5'-HA), TC body 
(containing a selectable marker and additional, application-dependent sequences) and a 3'-homology arm 
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(3'-HA) (Bouabe and Okkenhaug, 2013). HAs are necessary to facilitate HR and a common rule of thumb 
states that the longer the HAs the better the targeting efficiency is (Hasty et al., 1991; Deng and Capecchi, 
1992). They are usually, but not exclusively, derived from genomic DNA prepared from the same strain 
that is used for targeting to avoid mismatches (te Riele et al., 1992). Since TCs are often cloned into 
plasmids, they are often linearized before use to improve targeting efficiency (Thomas et al., 1986). 
Traditional HR-directed targeting works at low frequencies, so that only 10-2 to 10-3 of integrations are HR 
events (Melton, 2002), which makes screening for correct insertions labor-intensive. Double-strand breaks 
(DSBs) within the locus to be targeted enrich the HR events 100-fold (Jasin and Rothstein, 2013). Recent 
advancements in gene targeting take advantage of the fact that DSB induction at precise loci has become a 
routine with development of the zinc finger proteins (ZNFs; Hockemeyer et al., 2009), transcription 
activator-like effector nucleases (TALENs; Hockemeyer et al., 2011) and in particular the CRISPR-Cas9 
system (Wang et al., 2013). 
TC bodies are where the diversity of gene targeting applications is realized. The applications include gene 
knock outs and knock ins, point mutations, protein tagging, various deletions and many more. As previously 
mentioned, they most commonly consist of a selectable marker, ie. antibiotic resistance gene. This gene 
can be flanked by loxP sites (floxed) to allow for excision when selection is no longer necessary (reviewed 
in Bouabe and Okkenhaug, 2013). A modification of this approach is called gene trapping. A typical 5' 
trapping vector consists of a 5' splice acceptor (5' SA) and a promotorless antibiotic resistance gene that 
can be fused with another gene (Skarnes et al., 2011), eg. a reporter gene or a mutated version of the targeted 
gene, through internal ribosome entry site (IRES) or viral 2A peptide (Donelly et al., 2001; Szymczak et 
al., 2004) to facilitate expression of the two proteins as separate entities. Upon insertion of the gene trap 
into the intron of the targeted gene and expression of the mRNA, the resistance coding sequence (CDS) and 
the downstream fused CDSs are connected with the upstream exon via splicing mediated through the 5' SA. 
This essentially inactivates the targeted protein because all the exons located downstream of the inserted 
gene trap are no longer in frame (for an example of the described TC features, refer to Figure 3). 
Promotorless resistance genes are used to enrich the targeted cell populations with the gene traps that are 
correctly inserted into the intron of the targeted gene (Friedel et al., 2005) because the resistance protein 
can in such cases be expressed only if it is fused with the upstream exon. Apart from positive selection, 
negative selection is occasionally used to discriminate against non-homologous events. The most common 
negative selection genes used in gene targeting are thymidine kinase (TK) and diphteria toxin fragment A 
(DT-A), placed outside of HAs (Bouabe and Okkenhaug, 2013). During HR, sequences outside of HAs are 
usually lost but are retained upon random integrations. TK and DT-A proteins catalyze the conversion of 
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gancyclovir or ADP-ribose, respectively, to products that are toxic to the cell (Yagi et al., 1990; Mortensen, 
2006). 
The ubiquitous expression of transgenes and reporter genes is often desirable. In such cases, the TCs can 
be targeted into the ROSA26 mouse locus (Zambrowicz et al., 1997). ROSA (reverse orientation splice 
acceptor β-gal) promoter trap was first used in mESCs for a screen to identify developmental genes in mice 
(Friedrich and Soriano, 1991). It was subsequently discovered that one of the targeted loci, named ROSA26, 
exhibited ubiquitous expression in all hematopoetic cells as well as in all tissues of the embryo (Zambrowicz 
et al., 1997). One candidate for insertion into the ROSA26 locus is CreERT2 (Vooijs et al., 2001). Inducible 
Cre is especially useful when it comes to conditional mutagenesis, the goal of which is spatial and temporal 
control over SSR events. CreERT2 can be used both to delete a gene or to activate its expression (Lakso et 
al, 1992; Torres and Kuhn, 2003). Temporal control over the activation of gene expression is of high 
importance when it is desirable to avoid harmul effects of the transgene during the mouse embryogenesis 
(Bouabe and Okkenhaug, 2013) or limit potential toxicity as a result of prolonged high levels of Cre activity 
(Feil et al., 2009).  
 
Figure 3. Architecture of a typical gene targeting construct.  
Homology arms are depicted left and right of the loxP sites, with exons indicated as turquoise-white rectangles. SA – 
splice acceptor; IRES – internal ribosome entry site; Res. – resistance gene. Adapted from Kaulich and Dowdy, 2015. 
1.4.  CRISPR/Cas9-mediated genome engineering 
Clustered regularly interspaced short palindromic repeats (CRISPR) – CRISPR-associated protein 9 (Cas9) 
engineering is a genome editing technique that relies on naturally occuring bacterial immunity to viral or 
plasmid DNA sequences by incorporating stretches of these sequences (termed spacers) into CRISPRs of 
the bacterial host genome (Barrangou et al., 2007). The spacers act as templates to produce the so called 
pre-crRNA (Brouns et al., 2008), which upon binding to tracrRNA (Chylinski et al., 2013) matures into 
crRNA helped by RNase III and guides Cas9 towards the complementary site on the DNA where Cas9 
induces a DSB (Gasiunas et al., 2012; Jinek et al., 2012). 
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The ability to precisely introduce a DSB makes the CRISPR-Cas9 system an ideal tool for genome 
engineering. Mammalian cells respond to introduced DSBs by activating an error-prone repair process 
called non-homologous end joining (NHEJ) or, in case a homologous template is provided, homologous 
recombination (Ma et al., 2014). Instead of using two RNAs (cr- and tracrRNA) to target the desirable 
mammalian sequence, they are often combined into one single guide RNA (sgRNA; Jinek et al., 2012). In 
case of the most commonly used version of the CRISPR-Cas system, the one enabled by Cas9 protein from 
Streptococcus pyogenes, the genomic sequence of interest must contain an NGG motif (PAM sequence) 3 
bp downstream of the intended DSB site (Qi et al., 2013). Since sgRNA needs to recognize around 20 bp 
to introduce a cut, any N20-NGG sequence can be used as a target (Ma et al., 2014). 
As expected, Cas9 can also cause some off-target DSBs due to complementarity of the sgRNA to more than 
one sequence in the genome. This problem has been tackled by characterizing the off-target effects (Fu et 
al., 2013; Kuscu et al., 2014; Hsu et al., 2013), improving the sgRNA design (Doench et al., 2014; Fu et 
al., 2014; Kim et al., 2015), suggesting the use of longer, more stringent PAM sequences (Müller et al., 
2016) and developing Cas9 nickases (Mali et al., 2013; Ran et al., 2013; Shen et al., 2014), which require 
two sgRNAs and introduce two closely located single-stranded breaks, thus lowering the frequency of 
unwanted DSBs by doubling the recognition sequence length needed to introduce a DSB. 
CRISPR/Cas9 has so far been used for a variety of genome engineering purposes, including gene 
inactivation (Cong et al., 2013) or activation (Konermann et al., 2015), targeted DNA methylation (Vojta 
et al., 2016), gene visualization (Chen et al., 2013), genome-wide knockout studies (Wang et al., 2015) and 
knockin mice generation (Platt et al., 2014; Dow et al., 2015), to name a few. One of the very useful 
applications of the CRISPR-Cas9 system for the biomedical community, and the one that interests us the 
most, is the enhancement of gene targeting in mESCs (Zhang et al., 2014). It has recently been reported 
(Baker et al., 2017) that complex targeting exercises like gene humanization or creation of conditional 
alleles become a feasible task and require less screening effort by combining the repair of recombinogenic 
CRISPR-Cas9-induced DSBs with homology templates containing HAs of 1 kb or greater. 
1.5.  Chromatin structure 
Eukaryotic DNA is extremely long – each human cell contains about two meters of DNA. It is intuitively 
clear that DNA needs to be condensed on multiple levels to fit inside the μm3-sized eukaryotic nuclei. 
Indeed, the 10 000-fold DNA condensation is facilitated by packaging proteins which, together with the 
double-stranded DNA helix, form the nucleoprotein structure called the chromatin. Chromatin is comprised 
of repeating units called nucleosomes, which are formed by winding of DNA around the proteins called 
histones. Each nucleosome is an octamer consisting of two H2A-H2B histone dimers and a H3-H4 histone 
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tetramer, wrapping a stretch of 146 bp of DNA around itself. Further compation is accomplished by the use 
of H1 linker histone, which packages the nucleosomes into spiraled coils called 30 nm fibers. Nucleosomes 
can change their positions relative to the DNA seqence they are bound to and thereby substantially 
contribute to chromatin dynamics and degree of DNA packaging. 
Except from being associated with packaging proteins, DNA also extensively contacts proteins and RNA 
molecules required for gene expression, DNA replication and DNA repair (Alberts et al., 2008). The 
accessibility of DNA depends on the degree of its histone-mediated condensation. To facilitate binding of 
proteins needed to execute gene expression, DNA replication and repair, DNA needs to be decondensed by 
loosening its interation with histones. When histones were first discovered, it was thought that their only 
role is to compact the genome (Ramakrishnan, 1997). In the meantime it became clear that histones are 
active players in other processes involving the DNA, and that the regulation of processes such as DNA 
compaction-dependent transcription involves extensive and precise post-translational modifications 
(PTMs) of histones, such as acetylation, methylation, phosphorylation and ubiquitination, to name a few 
(reviewed in Bannister and Kouzarides, 2011). These modifications mostly take place on N-terminal tails 
of histones, which protrude from the nucleosome structure, making them easily accessible targets of PTMs.  
The study of histone PTMs and their functional role, currently one of the most attractive scientific areas, 
has proposed a well-established hypothesis of the histone code. That is, specific patterns of histone PTMs 
serve as molecular codes recognized and used by non-histone proteins to regulate a variety of chromatin 
functions (Tollefsbol, 2012). For example, acetylation of H3 lysine at position 27 (H3K27ac) leads to local 
chromatin decondensation and transcriptional activation (Tie et al., 2009). Acetylation neutralizes 
positively charged lysine residues, thus weakening their interation with the negatively charged DNA. Aside 
from changing the affinity of histone-DNA interactions, PTMs often serve as docking sites for other 
proteins, such as histone-modifying enzymes, chromatin remodelers and transcription factors. 
Chromatin structure is determined not only by histones and their modifying proteins, but also by non-
histone architectural proteins. Structural maintenance of chromosome (SMC) proteins can be divided into 
cohesin and condensin classes. As their names suggest, cohesins regulate the sister chromatid cohesion, 
while condensins contribute to chromosome condensation. These two protein classes are therefore essential 
for faithful chromosome segregation (Ball AR Jr and Yokomori, 2001). Topoisomerase II exhibits a 
decatanating activity, promoting chromosome disentanglement, and cooperates with SMCs as part of the 
protein network that stabilizes long range-contacts between chromosomal segments (Maeshima and 
Laemmli, 2003). HP1 proteins demarcate heterochromatin regions. They play an essential role in 
establishing constitutive heterochromatin at pericentromeric and telomeric sites (Krouwels et al., 2005). 
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CCCTC-binding factor (CTCF) facilitates the creation of highly conserved genomic functional units called 
topologically associated domains (TADs) by acting as a domain insulator (Vietri Rudan M et al., 2015). 
Worth mentioning are also the HMGB (High mobility group B) proteins, which exhibit multiple nucleus- 
and cytoplasm-associated functions, among which is the induction of local DNA conformational changes, 
i.e. the increase in DNA flexibility, through their sequence non-specific DNA binding activity (Zhang et 
al., 2009). All of the aforementioned proteins are found in eukaryotes, with prokaryotes having a different 
set of proteins responsible for DNA compaction, but whose identities and roles reach outside of the scope 
of this thesis. 
1.6.  DNA flexibility and looping 
Double-stranded DNA is the primary genetic storage material of all prokaryotic and eukaryotic organisms 
and some viruses. Being one of the longest natural polymers, it is subject to physical disortions such as 
bending, twisting, looping (Peters and Maher, 2010) and supercoiling. DNA bending represents sequence-
dependent DNA deformation driven by an external force, while curvature refers to the sequence-dependent 
DNA shape in a hypothetical thermal bath without an external force (Peters and Maher, 2010). DNA 
supercoiling represents the over- or underwinding of a DNA strand around its axis (Irobalieva et al., 2015). 
All of these processes are not only a consequence of DNA's physical properties but also play an important 
role in DNA storage and function. Some of the most prominent processes DNA is involved in include 
replication, transcription and recombination (Bellomy and Record, 1990; Schleif, 1992; Dillon et al., 1997). 
All of these depend on DNA looping. Sites of various distances dispersed along the DNA must be able to 
interact with each other to facilitate such looping, as is the case with transcription factors bound to 
promoters contacting distant enhancer elements. Apart from being extremely long, DNA is also surprisingly 
stiff in comparison to other natural polymers. It is precisely this DNA stiffness that makes the looping and 
packaging into µm3-range prokaryotic cells or eukaryotic nuclei difficult. Looping efficiency depends on 
the flexibility of DNA or chromatin and the distance between two sites involved in looping (Ringrose et 
al., 1999). 
Answering the questions surrounding DNA flexibility and looping are of great importance for 
understanding the above mentioned fundamental biological processes and development of applications such 
as DNA engineering in nanotechnology (Rothemund, 2006; Seeman, 2005) and DNA delivery in gene 
therapy (Peters and Maher, 2010). To quantitatively assess the inherent stiffness of a polymer like DNA 
and the energy cost of deforming it, a measure called persistance length (P, in nm) is used (Manning, 1988). 
Another useful measure expresses the probability that the two sites on the same DNA molecule will meet 
by looping as the local molar concentration of one site in respect to the other (jM, in M) (Kratky and Porod, 
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1949; Jacobson and Stockmayer, 1950; Hagerman, 1988; Rippe et al., 1995). A single coherent equation 
for jM that covers both short and long DNA distances has been developed by Ringrose et al. (1999). 
In their work, Ringrose et al. have taken advantage of SSR as a method of choice for DNA flexibility 
measurement. The frequency at which FLP- or Cre-mediated excition of the DNA substrate occurs depends 
on the probability that FRT or loxP sites will contact each other, which is in turn determined by their 
distance, orientation, accessibility and DNA flexibility. Changes in excision frequency are therefore directly 
correlated with DNA flexibility and permit its measurement when the sequence distance is experimentally 
controlled and factors like sequence accessibility and orientation are considered. 
The flexibility of DNA in vitro has been well studied, yielding a persistence length of 50 nm or around 150 
bp (Hagerman, 1988) and an optimum looping distance of 500 bp. DNA in mammalian chromatin is able 
to form smaller loops and has an optimum looping distance of 200 bp (Figure 4). Furthermore, the apparent 
persistence length is reduced to 27 nm in vivo (Ringrose et al., 1999). This shift in apparent DNA flexibility 
was attributed to chromatin properties. The propensity towards protein-mediated DNA loop formation is 
greatly affected by two factors: DNA compaction and binding site occlusion (Hildebrandt and Cozzarelli, 
1995). The compaction involves wrapping of DNA around the nucleosomes and higher order packaging 
and should contribute to increasing apparent DNA flexibility. The presence of nucleosomes and non-histone 
proteins can, on the other hand, occlude binding of proteins that bring the DNA sites into interaction. The 
relative contribution of these factors to DNA flexibility changes is based on the length of the DNA distance 
between the loop ends (Ringrose et al., 1999). 
 
Figure 4. Dependence of DNA flexibility measured by SSR efficiency on the distance between the excision sites on 
a linear piece od DNA.  
The y-axis represents relative recombination frequency. The figure was addapted from Ringrose et al., 1999. 
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Aside from the factors highlighted by Ringrose et al., there have been many other proposed factors that 
influence apparent local DNA flexibility and propensity of DNA to loop in vitro and in vivo, such as the 
concentrations of multivalent and divalent ions, conformational form of DNA (A-, B- or Z-DNA), histone-
mediated DNA compaction, the presence of the linker histone or non-histone architectural proteins (such 
as the ones reviewed in 1.5., in particular the HMGB proteins) and linker DNA length connecting the 
neighboring nucleosomes (Perisic and Schlick, 2017.; Perez et al., 2004; Perez et al., 2008; Zhang et al., 
2009; Ross et al., 2001). Of particular interest to us are the DNA flexibility changes brought on by local 
changes in DNA compaction, for instance the ones that occur during transitions from a transcriptionally 
active to a repressed state. It is believed that DNA compaction is accompanied by alterations in physical 
properties of chromatin, including its propensity to loop and engage in long-term interactions, which is 
crucial for regulatory interactions between enhancers and promoters. On top of flexibility changes caused 
purely by DNA compaction, pluripotent stem cells exhibit a peculiar nucleosomal phenomenon termed 
hyperactive or breathing chromatin (Zwaka, 2006), that could further influence the special status of DNA 
flexibility within these cells. To be able to investigate the effects of DNA compaction on in vivo DNA 
flexibility, we will use the mNanog gene as the environment for performing Cre-loxP based excision 
experiments. mNanog has been chosen because it is transcriptionally active in mESCs, contributing to the 
major characteristic of embryonic stem cells, ie. their pluripotency (Chambers et al., 2007). However, it is 
rapidly shut off upon differentiation of ESCs due to repressive chromatin remodelling (Wu et al., 2014) and 
Nanog promoter methylation by methylases Dnmt3a and Dnmt3b (Li et al., 2007), resulting in stable 
silencing due to heterochromatinization. Indeed, Nanog mRNA levels are decreased 105-fold in neural stem 
cells (NSCs; Lee et al., 2010). Differentiation of ESCs into NSCs is routinely performed in the host lab 
using the method of (Ying et al., 2003). mNanog is therefore a particularly suitable gene for bringing 
heterochromatinization into connection with altered DNA flexibility. 
As a continuation of the Ringrose et al. experiments, this project will try to improve on the previously used 
methods by employing the novel advancements in gene targeting (such as CRISPR-Cas9-assisted increase 
of targeting frequency). This means that our cell lines will have all the TCs necessary for flexibility 
measurement inserted into the same (mNanog) gene, contrary to the previous strategy of random TC 
insertion into the genome. This will make the project more conclusive, as the possible locus-dependent 
effects will be avoided. The significance of performing the described measurements and describing the 
mechanisms guiding the DNA flexibility and looping changes are numerous. We might for example be able 
to better predict the efficiency with which Cre-loxP recombination will occur depending on the gene's 
degree of compaction, or better estimate how likely the endogenous genetic elements are to contact each 
other depending on their distance and degree of compation. Furthermore, we will contribute to answering 
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some of the central questions associated with DNA flexibility, such as the extent to which proteins are 
needed to make the inherent DNA properties compatible with biological requirements (Peters and Maher, 
2010). 
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2. AIM OF THE THESIS PROJECT 
The aim of this lab project was to: 
1) Prepare the targeting constructs for mNanog targeting in R1 mESCs 
2) Test the CreERT2 inducibility in these cells 
3) Design and produce 5' and 3' Southern probe for mNanog targeting 
4) Target mNanog with 10 different targeting constructs and screen for correct insertions by 
Southern blot 
5) Develop a strategy for the PCR-based verification of positive colonies 
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3. MATERIALS AND METHODS 
3.1.  Materials 
3.1.1. Instrumentation 
Instrument name      Company 
5415D Benchtop Microcentrifuge    Eppendorf 
5415R Refrigerated Benchtop Microcentrifuge  Eppendorf 
5804 Cell Culture Centrifuge     Eppendorf 
BAS 2040 development cassette with imaging plate Fuji 
Blue light LED transilluminator    Carl Roth 
CASY Cell Counter (model TTC)    Roche 
Eporator        Eppendorf 
FLA-3000 Flourescence and Radioactivity Imager  Fuji 
G:Box gel documentation system    Syngene 
Gene Pulser Xcell™ Electroporation System   Bio-Rad 
Multitron Standard bacterial incubation shaker  Infors HT 
NanoDrop ND-1000 spectrophotometer   PeQLab 
Thermocycler ep Gradient S     Eppendorf 
Thermomixer compact      Eppendorf 
UV Stratalinker 1800      Stratagene 
 
3.1.2. Chemicals and reagents 
Product name       Company 
2-mercaptoethanol       Sigma 
2-propanol        VWR 
4-hydroxytamoxifen (4-OHT)     Sigma-Aldrich 
Agarose        Serva 
Ammonium Acetate      Sigma-Aldrich 
Ampicillin        Sigma-Aldrich 
Blasticidin S       Thermo Fisher 
Bovine Serum Albumin (BSA)     Sigma-Aldrich 
Bromphenol Blue       Merck Millipore 
CASYton        Omni Life Science 
Chicken Serum       Gibco Invitrogen 
CT-99021        ABCR 
D-glucose        Merck Millipore 
Dimethyl Sulfoxide (DMSO)     Sigma-Aldrich 
DMEM-High Glucose with GlutaMax    Gibco Invitrogen 
ESGRO (LIF)       Millipore 
Ethanol        VWR 
Ethidium Bromide       Sigma-Aldrich 
Ethylenediamine tetraacetic acid disodium salt dihydrate Merck Millipore  
Fetal Calf Serum       GAA 
Formaldehyde       Merck Millipore 
Gelatin from cold water fish skin    Sigma-Aldrich 
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Geneticin (G418 sulfate)      Gibco Invitrogen 
Glutaraldehyde       Merck Millipore 
Hydrochloric acid       VWR 
Kanamycin sulfate       Sigma-Aldrich 
L-Arabinose        Sigma-Aldrich 
L-Glutamine       Gibco Invitrogen 
Magnesium chloride (MgCl2)     Sigma-Aldrich 
MEM non-essential aminoacids     Gibco Invitrogen 
N-Lauroylsarcosine sodium salt     Sigma-Aldrich 
PD0325901        ABCR 
Penicillin        Gibco Invitrogen 
Phenol/chloroform/isoamyl alcohol (25:24:1)  Sigma-Aldrich 
Phosphate buffered saline (PBS)    Gibco Invitrogen 
Potassium ferricyanide      Sigma-Aldrich 
Potassium ferrocyanide      Sigma-Aldrich 
Puromycin        Sigma-Aldrich 
Radioactive [32P]dCTP – 3000 Ci/mmol   Perkin Elmer 
Sodium acetate hydrate      Sigma-Aldrich 
Sodium chloride (NaCl)      VWR 
Tri-Sodium citrate dihydrate     Merck Millipore 
Sodium dodecyl sulfate (SDS)     Carl Roth 
Di-Sodium hydrogen phosphate dihydrate   Carl Roth 
Sodium hydroxide pellets (NaOH)    Merck Millipore 
Sodium pyruvate       Gibco Invitrogen 
Spermidine        Sigma-Aldrich 
Streptomycin       Gibco Invitrogen 
Tetracyclin        Sigma-Aldrich 
Tris         Carl Roth 
Tris-Acetate-EDTA (TAE)     AppliChem 
Tris-Borate-EDTA (TBE)     AppliChem 
Trypsin/EDTA       Gibco Invitrogen 
X-Gal        Fermentas 
Xylene cyanol FF       Sigma-Aldrich 
 
3.1.3. Kits, enzymes, ladders 
Product name       Company 
1 kb DNA ladder       NEB 
dNTP mix (10 mM each)      NEB 
High Prime DNA labeling kit     Roche 
Invisorb Fragment CleanUp     Stratec 
Invisorb Spin DNA Extraction Kit    Stratec 
Phusion DNA polymerase     NEB 
Plasmid Maxi Kit       QIAGEN 
Proteinase K       Merck 
Restriction nucleases + buffers     NEB 
RNase A        QIAGEN 
Taq DNA polymerase      NEB 
T4 ligase and buffer      NEB 
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3.1.4. Buffers and media 
6x Saline sodium citrate (SSC; Southern blot) 
• 300 mL of 20x SSC + 700 mL ddH2O 
Table 1. 20x SSC (Southern blot) 
Reagent Amount 
ddH2O up to 1 l 
  
Na-citrate 87.66 g 
NaCl 20 g 
 
Table 2. Southern blot DNA loading dye 
Reagent Amount 
Bromphenol blue 25 mg 
Xylene Cyanol FF 25 mg 
Sucrose 4 g 
Deionized water Up to 10 ml 
 
Table 3. Cell lysis buffer (Southern blot) 
Reagent Amount 
ddH2O up to 0.5 l 
1 M Tris (pH 7) 5 ml 
0.5 M EDTA 10 ml 
1 M NaCl 5 ml 
N-Lauroylsarcosine 2.5 g 
Add fresh before use: 
20 mg/ml Proteinase 
K 
1:100 V/V 
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Table 4. CG-wash (Southern blot) 
Reagent Amount 
ddH2O 908 ml 
0.5 M Na2HPO4 x 
2H2O pH 7.2 
40 ml 
0.5 M EDTA pH 8 2 ml 
20 % SDS 50 ml 
 
Table 5. Denaturation buffer (Southern blot) 
Reagent Amount 
ddH2O up to 1 l 
NaCl 87.66 g 
NaOH 20 g 
 
Depurination solution (Southern blot) 
• 21.5 ml of 37 % HCl and 978.5 ml ddH2O 
 
Table 6. Fixative solution (X-gal staining) 
Reagent Amount 
1x PBS 11.78 ml 
37 % formaldehyde 675 µl 
25 % glutaraldehyde 50 µl 
 
Table 7. Hybridization buffer (Southern blot) 
Reagent Amount 
ddH2O 148 ml 
0.5 M Na2HPO4 x 
2H2O pH 7.2 
500 ml 
0.5 M EDTA pH 8 2 ml 
20 % SDS 350 ml 
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Table 8. mESC medium 
Reagent Amount 
DMEM-High Glucose 
+ GlutaMax 
148 ml 
FCS 75 ml 
10 mM  
2-mercaptoethanol 
5 ml 
Penicillin-
Streptomycin 5000 
units/ml 
5 ml 
200 mM L-Glutamine 5 ml 
100x Non-essential 
aminoacids 
5 ml 
100 mM Sodium 
pyruvate 
5 ml 
self-made 
recombinant 
Leukemia inhibitory 
factor (LIF) 
1 ml 
10 mM CT-99021 75 µl 
10 mM PD-0325901 25 µl 
Antibiotic* Amount 
50 mg/ml  
Geneticin G418 
2 ml 
1 mg/ml Puromycin 500 µl 
5 mg/ml  
Blasticidin S 
500 µl 
*Up to two mammalian antibiotics can be combined. In case multiple antibiotic resistance needs to be selected for, 
antibiotic combinations can be changed every four days during medium changes/cell splits. 
Table 9. Neutralization buffer (Southern blot) 
Reagent Amount 
ddH2O up to 1 l 
Tris 121.14 g 
NaCl 87.66 g 
Adjust pH to 7 before use. 
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Table 10. Staining solution (X-gal staining) 
Reagent Amount 
1x PBS 9.9 ml 
1 M MgCl2 25 µl 
50 mM Potassium 
ferricyanide* 
1.25 ml 
50 mM Potassium 
ferrocyanide* 
1.25 ml 
200 mg/ml X-gal# 62.5 µl 
*Can be kept at 4°C for 14 days. 
#Heat the solution to 50°C before adding X-gal to avoid crystallization. 
Table 11. 0.1 % trypsin for cell culture 
Reagent Amount 
PBS 500 ml 
2.5 % trypsin 20 ml 
Chicken serum 5 ml 
EDTA 0.1 g 
D-glucose 0.5 g 
 
3.1.5. Primers 
Table 12. List of primers 
Primer name Primer sequence 5'3' Application 
mNanog-Bsd-
replacement-F 
GCTTACATAAACAGTAATACAAGGGG 
TGTTATGGCCAAGCCTTTGTCTCAAG 
Recombineering 
mNanog-Bsd-
replacement-R 
TGGCAACTAGAAGGCACAGTCGAGGCTG 
ATCAGCGTTAGCCCTCCCACACATAACC 
Recombineering 
mNanog 5' F GTACGAATTCGCGGGTGTCCTTATCACTCT 5' Southern blot 
probe production 
mNanog 5' R AGACGGATCCGAGCTTCAGACCTTGGCTCC 5' Southern blot 
probe production 
mNanog 3' F GTACGAATTCTAAGTTAACGTAACTCCTGATGC 3' Southern blot 
probe production 
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mNanog 3' R AGACGGATCCAGGTGGAATTAGTCTGGGCTT 3' Southern blot 
probe production 
850/1566 F CGGTGGATGTGGAATGTGTG Gene targeting 
validation 
850/1566 R CCTGCAGAGTGACAGGACAT Gene targeting 
validation 
2359 F TTTTGAAGCGTGCAGAATGCC Gene targeting 
validation 
2359 R CTGGGGATAGCTGCAATGGAT Gene targeting 
validation 
3.1.6. Strains 
Table 13. List of E. coli and mESC strains 
Strain name Characteristics Reference 
E. coli 
GB05 F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 endA1 araD139Δ(ara, leu)7697 galU 
galK λ- rpsL nupG fhuA::IS2 recET redα, phage T1-
resistent 
Fu et al., 2010 
mESCs 
E14 E14 ROSA26 CreERT2 ROSA26 Konstantinos 
Anastassiadis, 
BIOTEC, 
Germany 
R1 13-18 R1 ROSA26 CreERT2 ROSA26 loxP-Neo-loxP-lacZ K. Anastassiadis 
R1 13-23 R1 ROSA26 CreERT2 ROSA26 loxP-Neo-loxP-lacZ K. Anastassiadis 
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3.1.7. Plasmids 
Table 14. List of plasmids 
Plasmid name Plasmid description Application Reference 
pETgA pSC101-BAD-ETgA-TetR Recombineering (source of  
HR-promoting proteins) 
Fu et al., 
2012 
pBsd-replace pR6K-hyg-NLS-mTIR1-IRES-gb3-
Bsd 
Recombineering (source of 
Bsd cassette) 
Stewart lab 
pNeo-70 pBR322-amp-mNanog-Neo-70 Recombineering (source of 
targeting construct) 
Jun Fu, 
Shandong 
University, 
China 
pNeo-75 pBR322-amp-mNanog-Neo-75 
pNeo-90 pBR322-amp-mNanog-Neo-90 
pNeo-120 pBR322-amp-mNanog-Neo-120 
pNeo-150 pBR322-amp-mNanog-Neo-150 
pNeo-200 pBR322-amp-mNanog-Neo-200 
pNeo-400 pBR322-amp-mNanog-Neo-400 
pBlue pBlueScript KS 5'- and 3'-mNanog Southern 
blot probe production 
Addgene 
pCas9 Caggs-Cas9-NLS Gene targeting (source of 
Cas9) 
Stewart lab 
pgRNA-
mNanog 
pBR322-U6-mNanog-tracrRNA-Amp Gene targeting (source of 
mNanog gRNA) 
Stewart lab 
pBsd-70 pBR322-amp-mNanog-Bsd-70 Gene targeting (targeting 
contruct) 
This work 
pBsd-75 pBR322-amp-mNanog-Bsd-75 
pBsd-90 pBR322-amp-mNanog-Bsd-90 
pBsd-120 pBR322-amp-mNanog-Bsd-120 
pBsd-150 pBR322-amp-mNanog-Bsd-150 
pBsd-200 pBR322-amp-mNanog-Bsd-200 
pBsd-400 pBR322-amp-mNanog-Bsd-400 
pBsd-850 pBR322-amp-mNanog-Bsd-850 
pBsd-1566 pBR322-amp-mNanog-Bsd-1566 
pBsd-2359 pBR322-amp-mNanog-Bsd-2359 
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3.2. Methods 
3.2.1. Genetic engineering methods 
Small-scale DNA purification (miniprep) 
Plasmid DNA was purified via alkaline lysis miniprep using QIAGEN buffers. A single bacterial colony 
was picked and incubated overnight at 37°C with 950 rpm shaking in 1.8 ml of LB medium supplemented 
with appropriate antibiotics. The following day, cultures were centrifuged at 13200 rpm for one minute 
and the supernatant was decanted. 200 µl of P1 (resuspension) buffer were added to each pellet and 
shaken at 1300 rpm at room temperature (RT) for 10 minutes to resuspend the cells. 200 µl of P2 (lysis) 
buffer were added and the samples were shaken three times for five seconds at 1300 rpm. 200 µl of P3 
(neutralization) buffer were added and the samples were shaken three times for five seconds at 1300 rpm. 
The tubes were inverted gently three times. The lysates were then centrifuged at 13200 rpm for 10 
minutes. The supernatants were transferred into new 1.5 ml tubes with 500 µl of 100 % isopropanol and 
vigorously mixed, then centrifuged at 13200 rpm for 20 minutes. The supernatants were decanted and the 
pellets washed with 500 µl of 70 % ethanol. The DNA pellets were dried at 42°C to remove residual 
ethanol. They were dissolved in deionized water and stored at 4°C for short-term or at -20°C for long-
term storage. The added water volumes depend on the plasmid ori: for pBR322 50 µl, for pBlueScript 60 
µl. 
Large-scale DNA purification (maxiprep) 
The plasmid DNA was purified using the QIAGEN Plasmid Maxi Kit. The bacterial colonies were picked 
and incubated overnight at 37°C with 200 rpm shaking in 200 ml LB medium supplemented with 
appropriate antibiotics. The following day, cultures were centrifuged at 4°C at 6000 rpm for 15 minutes 
and the supernatant was decanted. The pellets were resuspended on ice in 10 ml of P1 (resuspension) 
buffer by pipetting up and down and vortexing. 10 ml of P2 (lysis) buffer were added, the samples were 
thoroughly mixed and incubated at RT for five minutes. 10 ml of P3 (neutralization) buffer were added, 
the samples were throughly mixed and incubated on ice for 20 minutes. During this incubation, QIAGEN-
tips 500 were equilibrated with 10 ml QBT (equilibration) buffer using folded qualitative filter papers. 
The samples were centrifuged at 4°C at 6000 rpm for two minutes and the supernatants were transferred 
into the QIAGEN-tips 500 and cleared by gravity flow. After the supernatant was cleared, the filter papers 
were discarded and the QIAGEN-tips washed two times with 30 ml QC (washing) buffer. The QIAGEN-
tips were transferred into 50 ml tubes and the DNA was eluted with 15 ml QF (elution) buffer. The DNA 
was mixed with 10.5 ml of 100 % isopropanol and centrifuged at 4°C at 9000 rpm for one hour. The 
supernatants were decanted, the pellets washed and resuspended in 2 ml of 70 % ethanol and transferred 
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into 1.5 ml tubes (2 per one sample). They were centrifuged at RT at 13 200 rpm for 10 minutes. The 
supernatants were removed with a pipette and the DNA pellets dried at 50°C. They were dissolved in 75 
µl of deionized water and stored at 4°C for short-term or at -20°C for long-term storage. 
Plasmid restriction digestion 
Table 15. Mixture for restriction enzyme-mediated plasmid digestion 
Reagent Volume per sample (µl) 
H2O Up to 10 Up to 40 Up to 100 
DNA 4 10 25 
Restriction enzyme 0.2 0.8 2 
Buffer 1 4 10 
Total volume 10 40 100 
 
Bacterial transformation by electroporation 
Bacterial cells were incubated with 1.4 ml of LB at 37°C at 950 rpm overnight. 40 µl of the overnight 
culture were added to 1.4 ml of fresh LB and incubated at 37°C at 950 rpm for two hours to allow the cells 
to reach the exponential growth phase. The cultures were centrifuged at 4°C at 9000 rpm for 30 seconds 
and the supernatants were decanted. 1 ml of cold deionized water was added and the pellets were 
resuspended by vortexing. Samples were centrifuged at 4°C at 10000 rpm for 30 seconds and all but the 30 
µl of supernatant was decanted. The appropriate plasmid was added and the contents were transferred into 
a cooled, 1 mm electroporation cuvette. The plasmids were electroporated using the Eppendorf Eporator at 
1350 V. 1 ml of LB was added and the cells were transferred into a new 1.5 ml tube and recovered at 37°C 
at 900 rpm for one hour. The bacteria were then streaked out onto 10 ml LB plates supplemented with the 
appropriate antibiotic(s) to obtain single colonies and incubated at 37°C over night. 
Dialysis of DNA 
10 ml empty plates were filled with deionized water and a Milipore 0.025 µm dialysis membrane was placed 
on the water surface. The entire volume of the DNA solution was pipetted onto the middle of the membrane 
and left to dialyze for 30 minutes. The dialyzed samples were collected into 1.5 ml tubes without disturbing 
the membrane. 
Agarose gel electrophoresis 
0.8 % gels were used for electrophoresis of DNA samples. 0.48 g of agarose were added to 60 ml of TBE 
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buffer and heated until the mixture was homogenously transparent. After short cooling, 2 µl of 10 mg/ml 
EtBr were added and the mixture was poured into the agarose electrophoresis chamber. The combs were 
added and the gel was left to solidify. The combs were removed, the chamber was filled with TBE until the 
gel was completely covered, the samples with 1:6 purple NEB loading dye were loaded and the gel was run 
at 95 V for 40 minutes or until sufficient band separation was accomplished. 1kb NEB ladder was used for 
to compare the sized of experimental DNA samples. 
Polymerase chain reaction (PCR) 
Table 16. Mixture and cycling parameters for the Taq-based PCR 
Reagent Volume per 
sample (µl) 
Step Temperature 
(°C) 
Time 
(s) 
dH20 37.5 Initial denaturation 98 10 
10x Taq buffer 5 30 cycles 98 5 
dNTPs (10 mM) 2  60 20 
DMSO 2  68 30 
forward primer (10 µM) 1 Final extension 68 60 
reverse primer (10 µM) 1 Hold 4  
5prime Taq 0.5    
DNA 1    
Total volume 50    
 
Table 17. Mixture and cycling parameters for the Phusion-based PCR 
Reagent Volume per 
sample (µl) 
Step Temperature 
(°C) 
Time 
(s) 
H20 34.5 Initial denaturation 98 30 
5x Phusion buffer 10 30 cycles 98 5 
dNTPs (10 mM) 2  55 10 
forward primer (10 µM) 1  72 20 
reverse primer (10 µM) 1 Final extension 72 60 
Phusion Pol 0.5 Hold 4  
DNA (100 ng/µl) 1    
Total volume 50    
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DNA purification from the PCR reaction mix 
The PCR products were transferred into 1.5 ml tubes and 250 µl of binding buffer were added. The contents 
were mixed and transferred into a spin filter inside a 2 ml tube. After centrifugation at 11000 rpm for two 
minutes, the flowthrough was discarded and the spin filters were placed into a new 1.5 ml tube. 20 µl of 
deionized water were placed onto the center of the filter and incubated at RT for 10 minutes. After 
centrifugation at 11000 rpm for one minute, the purified DNA was stored at -20°C. 
DNA ligation and blue-white screen 
Linearized and restricted pBlue and PCR product were incubated at a mass ratio of 1:3 at RT for one hour. 
The ligation mix contained the following: 
Table 18. Mixture for DNA ligation 
pBlue 2 µl (25 ng) 
PCR product 1 µl (10 ng) 
Ligation buffer 2 µl 
 dH20 15 µl 
T4 ligase 1 µl 
 
After ligation, T4 ligase was heat-inactivated at 65°C for 10 minutes.  
LB agar plates were prepared for the blue-white screen by adding a mixture of 40 µl of LB, 10 µl of IPTG 
and 20 µl of X-gal onto their surface and distributing it evenly. They were kept in the dark until streaking. 
The ligated DNA was dialysed as previously described. The DNA was transformed into GB05 E.coli by 
electroporation and streaked as previously described. Plates were screened the next day and 12 white 
colonies per ligation event were picked and miniprepped for purposes of gene cloning validation by plasmid 
restriction digestion and sequencing. 
Purification of DNA fragments from the gel 
Linearized plasmid fragments that were subsequently used for [32P]dCTP-labelled Southern probe synthesis 
were visualized using the blue light LED transilluminator, excised from the gel and transferred into 2 ml 
tubes. 1 ml of Gel Solubilizer S per tube was added and the samples were incubated at 50°C shaking at 300 
rpm for 10 minutes. 500 µl of Binding Enhancer were added, mixed and 750 µl of the mix were loaded into 
purification columns inside receiver tubes. The samples were centrifuged at 11000 rpm for one minute. The 
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loading and centrifugation were repeated until the entire mix volume was used. 500 µl of the Wash Buffer 
were added and centrifuged at 12 000 for 30 seconds. The washing step was repeated. The samples were 
centrifuged at 13200 rpm for four minutes. 25 µl of deionized water was added onto the filter, incubated at 
RT for five minutes and centrifuged into a receiver tube at 12 000 rpm for one minute. The samples were 
stored at 4°C or -20°C. 
 DNA precipitation 
1:10 (V/V) of 3 M sodium acetate and three volumes 100 % ethanol were added to the DNA sample to be 
precipitated and kept at -80°C for 10 minutes. The samples were centrifuged at 4°C at 13200 rpm for 20 
minutes. The supernatant was discarded, the samples were washed with 300 µl of 70 % ethanol and dried 
at 42°C for 30 minutes. The DNA was resolved in 50 µl of deionized water. 
Recombineering 
E. coli GB05 cells containing the pETgA plasmid were grown in LB-Tet40 overnight at 30°C and 950 rpm. 
As a template for the 50 µL PCR reaction, pBsd-replace plasmid was used. The primers used for Bsd 
cassette amplification are mNanog-Bsd-replacement-F and mNanog-Bsd-replacement-R. 1 µM of primers 
and 100 ng of the template were used in the Phusion-mediated PCR reaction. The fresh GB05 pETgA 
culture was prepared by incubating the overnight culture for two hours in LB-Tet40 at 30°C and 950 rpm. 
The PCR products were column purified. The expression of recombineering proteins was induced by adding 
20 µL of 10 % arabinose for 40 minutes at 37°C and 950 rpm. 70 µg of the PCR product and 150 ng of the 
NcoI-digested pNeo-(75-400) constructs were used for electroporation into GB05 pETgA cells. The cells 
were plated onto LS-LB + Bsd plates and subsequently examined for correct recombineering events by 
DNA isolation, PvuII-mediated digestion and DNA sequencing. 
3.2.2. Mammalian cell culture methods 
Mouse embryonic stem cell thawing 
R1 ROSA26 CreERT2 ROSA26 loxP-Neo-loxP-lacZ mESCs kept in liquid nitrogen were thawed rapidly 
in a 37°C water bath. The cryo tube contents were added into 4 ml of mESC medium. They were centrifuged 
at 1000 rpm for five minutes to remove the DMSO. After aspirating the supernatant, the pellet was 
resuspended in 10 ml of mESC medium, plated onto 10 cm plate and incubated in the 5 % CO2 incubator. 
Mouse embryonic stem cell passaging 
The medium was aspirated and the cells were washed with 5 ml of PBS. 1 ml of 0.1 % trypsin was added 
and incubated for five minutes at 37°C. mESC medium was added to 10 ml of cell suspension. 20 µl of cell 
suspension were mixed with 8 ml of CASYton buffer and counted using the CASY Cell Counter. The 
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remainder of the cell suspension was centrifuged at 1000 rpm for five minutes. Cells were resuspended and 
a defined amount was transferred to new 10 cm dishes with 10 ml mESC medium to achieve the desired 
cell number, depending on the application. The cells were incubated in the CO2 incubator. 
Mouse embryonic stem cell freezing 
The cells were incubated with 1 ml of 0.1 % trypsin for five minutes in the CO2 incubator and centrifuged 
at 1000 rpm for five minutes. The supernatant was aspirated and the pellet resuspended in 500 µl of mESC 
medium. 500 µl of 2x freezing medium (DMEM supplemented with 20 % FCS and 20 % DMSO) were 
added dropwise to the cell suspension, transferred into cryo tubes and flash frozen at -80°C and moved to 
liquid nitrogen witin a week. 
Transformation of mouse embryonic stem cells by electroporation 
The mESCs were washed with 5 ml of PBS, trypsinized and resuspended in mESC medium to inactivate 
the trypsin. They were counted as described in the section on mESC passaging and centrifuged at 1000 rpm 
for five minutes. After resuspension in 10 ml of PBS, a desired amount of cells was taken to get 5*106 cells 
per electroporation. They were centrifuged again at 1000 rpm for five minutes and resuspended in 800 µl 
of PBS + 10 µg of linear TC + 5 µg of pCas9 plasmid + 15 µg of pgRNA-mNanog plasmid. The samples 
were put into ice-cold 4 mm electroporation cuvettes. Electroporation was conducted using exponential 
protocol, 250 V, 500 µF and no set capacitance. The cells were recovered at RT for five minutes and 
resuspended in 4.5 ml of mESC medium. 1 ml of cell suspension (about 1x106 cells) and 9 ml of mESC 
medium were plated and incubated in the CO2
 incubator. Five plates were used per electroporated sample. 
CreERT2 inducibility test 
Six samples of R1 ROSA26 CreERT2 ROSA26 loxP-Neo-loxP-lacZ cells were plated in a 6-well plate at 
a density of 2.5*105 cells/well and selected with Puro. After 24 hours, two of the samples they were treated 
with mESC + Puro medium suppl. with 10-7 M 4-OHT and medium was changed for the other wells without 
adding the 4-OHT. After 24 hours, the treatment was repeated for the mentioned two samples and two more 
samples were treated the same way, while the medium was changed without adding 4-OHT for the negative 
control samples. After 24 hours, all the wells were washed with PBS and the fixative solution was added 
for two minutes. The wells were washed three times with PBS, the staining solution was added and samples 
were incubated overnight at 37°C. The following day, cells were washed with PBS and imaged with a 
bright-field microscope. 
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3.2.13. Southern blotting 
Cells grown in 10 cm plates were incubated with 1ml of Lysis Buffer suppl. with 10 µl of 10 mg/ml 
Proteinase K at 55°C at 900 rpm overnight. For 24-well plate samples, 200 µl of Lysis Buffer supplemented 
with proteinase K were used per well. 
For 10 cm plate samples, DNA was isolated by adding 500 µl of phenol/chloroform per 500 µl of cell lysate. 
The mixture was incubated at 4°C at 7 rpm for one hour and then centrifuged at RT at 10000 rpm for 10 
minutes. The upper phase was transferred into a new tube, incubated with 500 µl of 
phenol/chloroform/isoamyl at 4°C at 7 rpm for one hour and then centrifuged at RT at 10000 rpm for 10 
minutes. The upper phase was transferred into a tube containing 350 µl of 100 % isopropanol and 20 µl of 
3M sodium acetate, mixed and centrifuged at RT at 13200 rpm for 20 minutes. The supernatant was 
decanted and DNA washed with 500 µl of 70 % ethanol. The pellet was dried at 42°C for one hour. The 
DNA was dissolved in 200 µl of deionized water and stored at 4°C. 
In case of 24-well plate samples, DNA was isolated by adding 400 µl of ice-cold 100 % ethanol suppl. with 
20 % of 3M sodium chloride per well and incubating at RT for 30 minutes. The solution was discarded and 
the wells were washed two times with 300 µl of 70 % ethanol. The plates were dried at 50°C for one hour. 
DNA was digested using the following mixture (Table 19): 
Table 19. Mixture for mESC gDNA digestion used for Southern blotting 
Reagent Amount per 1.5 
ml tube or per 
well 
gDNA 20 µg 
CutSmart buffer 4 µl 
BSA 100x 0.4 µl 
Spermidin 100 mM 0.4 µl 
Rnase A 10 mg/ml 0.4 µl 
Restriction enyzme 3 µl 
Deionized water 31.8 µl 
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The samples were incubated overnight at 37°C. In case of samples from 24-well plates, the entire amount 
of DNA available in the well after precipitation was used for digestion because less than 20 µg were usually 
available. 
Digested DNA was analysed on a 0.8 % agarose gel prepared using 400 ml of TBE buffer. The 1 kb NEB 
ladder was diluted 1:50 and 3 µl were mixed with 5 µl of Southern blot DNA loading dye. 5 µl of the dye 
were added per sample. The gel was run at 80 V for five hours.  
The gel was stained for 15 minutes with 5 % EtBr solution and examined for transfer efficiency using the 
G:box gel documentation system. It was incubated 2 x 15 minutes with 500 µl of denaturation solution, 
washed with water and incubated 15 minutes with neutralization solution. The transfer system was 
assembled by laying the plexi-glass cover onto the transfer chamber filled with 400 ml of 20x SSC buffer. 
The glass was covered with a 2-layer Whatmann paper bridge immersed in the 20x SSC buffer from both 
ends. The bridge was topped with the gel (flipped upside down), the positively charged nylon transfer 
membrane, one wet and two dry blotting papers, paper towels and 250 g of weight per gel and left to transfer 
overnight at RT. The membrane was rinsed with 6x SSC and dried for five minutes at RT. It was UV-
crosslinked using the UV Stratalinker 1800 set at auto-crosslink mode (1200 µJ x100) and subsequently 
baked at 80°C for two hours. It was stored at RT. 
The hybridization buffer was pre heated to 55°C. The membrane was placed in the hybridization tube, DNA 
side facing the inside of the tube. It was rinsed with 30 ml of 6x SSC to make it wet and fix it to the 
hybridization tube. The 6x SSC was decanted and 8 ml of hybridization buffer were added. The membrane 
was prehybridized at 63°C at 15 rpm for one hour. 
During prehybridization, 100 ng of the probe template DNA were pipetted, filled with deionized water up 
to 13 µl and incubated at 99°C for 10 minutes. The tube was then immediately cooled down on ice for one 
minute and short-spin centrifuged. 4 µl of the High Prime mix were added and the mixture was put on ice. 
3 µl of CTP [32P-α] were added and incubated at 37°C for 30 minutes.  
A G-25 sepharose column was provided and the liquid was removed from the column by centrifugation in 
a 15 ml falcon with a 1.5 ml collection tube inside at 1000 rpm for two minutes. The collection tube was 
replaced and the Southern probe was added to the middle of the column and spun down at 1000 rpm for 
four minutes. The column was discarded and the Southern probe transferred into a fresh 1.5 ml tube. 1:100 
dilution of the Southern probe was made to measure the counts per minute (CPM). The rest was incubated 
at 99°C for 10 minutes, then cooled down on ice and spun down. The hybridization buffer was decanted 
and 7 ml of the fresh hybridizatin buffer was added to the hybridization tube. The Southern probe was 
added to the bottom of the tube. The system was incubated at 63°C at 15 rpm overnight. 
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The hybridization buffer was decanted and the membrane incubated with 20 ml of CG-wash at 61.5°C at 
15 rpm for 20 minutes. The washing step was repeated. The CG-wash was decanted and the membrane was 
wrapped in a plastic wrap and put into the BAS development cassette. The imaging plate was exposed to 
bright light twice for 30 minutes to remove old readings and put on top the the wrapped membrane, inside 
the BAS development cassette for 24 hours. The film was developed using the FLA-3000 Imager (16 
bits/pixel). 
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4. RESULTS 
4.1.  Cell line validation 
Two lines of R1 ROSA26 CreERT2 ROSA26 loxP-Neo-loxP-lacZ cells were obtained from Konstantinos 
Anastassiadis (BIOTEC, Dresden, Germany), namely R1 13-18 and R1 13-23. Special genetic elements 
relevant for subsequent experiments that are present in those lines are shown in Figure 5. The cells were 
first weaned off of MEF mitomycin-C inactivated feeder layer and then checked for inducibility of 
CreERT2 using the X-gal test, as indicated in Figure 6. Upon 4-OHT-mediated CreERT2 induction for 24 
or 48 hours, the neo gene flanked by loxP sites should be excised. This allows for expression of β-
galactosidase, which reacts with X-gal to produce an indigo colored product. Both R1 13-18 and R1 13-23 
showed negligible background CreERT2 nuclear activity and strong CreERT2 inducibility upon 4-OHT 
administration. Because both lines showed the same inducibility, R1 13-18 line was chosen at random for 
the targeting experiments. 
 
Figure 5. Special genetic elements inserted into each ROSA26 allele of the R1 mESCs.  
The upper picture represents the CreERT2 expression cassette. CreERT2 is constitutively expressed from the ROSA26 
promoter and its cellular localization is controlled by 4-OHT administration. The PuroR gene was used during the cell 
line production for positive selection of the CreERT2 cassette insertion and was continuously selected for later on to 
prevent the loss of the CreERT2 expression. The lower picture represents the lacZ Cre reporter cassette. The role of 
this allele in validation of CreERT2 inducibility is described in the text. This allele will also be used for normalization 
in DNA flexibility measurements, since the distance of loxP sites within this locus is the same in all the targeted lines 
that we have subsequently produced. 
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Figure 6. X-gal test of CreERT2 inducibility on R1 13-18 and R1 13-23 mESC.  
The leftmost samples represent negative control and were not treated with 4-OHT. The samples in the middle column 
were treated with 4-OHT for 24 hours and the rightmost samples were treated for 48 hours, as indicated on the picture. 
4.2.  Targeting construct preparation 
To obtain TCs suitable for targeting of R1 13-18 mESCs, the Neomycin resistance gene (Neo) contained 
in the TCs obtained from Jun Fu (Shandong University, State Key Laboratory of Microbial Technology, 
China) had to be exchanged for a Blasticidin S resistance gene (Bsd). This was done because Neo is already 
integrated in the genome of the aforementioned cell line so another resistance gene was necessary to select 
for targeting events. To achieve this, we used recombineering (homologous recombination-mediated 
genetic engineering in E. coli), a genetic engineering method partly developed (Murphy, 1998; Zhang et 
al., 1998) and commonly used in our lab. The method takes advantage either of phage lambda HR-mediating 
proteins Redα and Redβ or prophage Rac proteins RecE and RecT, which carry out the same function. To 
inhibit E. coli's exonuclease activity, its RecBCD exonuclease and recombination protein complex needs 
to be inhibited by introduction of the lambda-encoded Gam protein. Most E. coli strains used for cloning 
are RecA-deficient to eliminate unwanted recombination events and thus increase the stability of the cloned 
DNA. However, it has been noticed (Wang J et al., 2006) that transient expression of RecA during 
recombineering events enhances the number of successful recombinations, presumably by allowing E. coli 
to better survive the DNA transformation procedures. 
We used the temperature-sensitive pETgA plasmid (see Materials) for recombineering purposes in E. coli 
GB05 strain. The ETgA operon (RecE RecT Gam RecA) is controlled by the arabinose-inducible pBAD 
promoter. The TC plasmids containing Neo cassettes that needed to be exchanged for Bsd are pBR322-
amp-mNanog-Neo-(70-400), which we abbreviate as pNeo-(70-400). All the other TCs already contained 
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a Bsd gene (pBsd-850, -1566 and -2359). The numbers in the parentheses reflect the distance of one loxP 
site to another, namely 70, 75, 90, 120, 150, 200, 400, 850, 1566 and 2359. To be more precise, this distance 
is the size of one loxP site plus the spacer between the loxP sites that has been left after FLP-FRT and Dre-
rox recombination. TC schemes are depicted in Figure 7. The most complex constructs (ie. pBsd-850, -
1566, and -2359) additionally contain sites for FLP-FRT and Dre-rox recombination, which enables us to 
increase the effective number of loxP distances from 10 to 23. For further clarification, refer to Table 20. 
 
Figure 7. Gene targeting construct schemes.  
A) mNanog-Bsd-(70-90) scheme. Numbers in parentheses (70, 75, 90) represents the size of one loxP site and 
intervening DNA up to beginning of another loxP site. 3'-HA is 4519 bp and 5'-HA is 2140 bp long. They are not fully 
shown. SA: 5' splice acceptor; T2A: viral T2A peptide; gb3: mammalian globotriaosylceramide promoter; pA: polyA. 
B) mNanog-Bsd-(120, 150, 200, 400) scheme. For more information, see 7.A. C) mNanog-Neo-Bsd-(850, 1566, 2359) 
scheme. EM7: synthetic T7-promoter-based bacterial promoter for Bsd expression in bacteria; PGK: mouse 
phosphoglycerate kinase 1 promoter. For more information, see 7.A. Note: vectors for TC cloning additionally contain 
pBR322 ori and ampicillin resistance gene. 
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Table 20. Summary of loxP distances present in targeting constructs.  
For constructs which additionally contain FRT and rox sites, intermediate loxP distances are possible after FLP-FRT 
or Dre-rox recombination. The intermediate distances differ depending on whether FLP-FRT or Dre-rox 
recombination is conducted first. Distances which are used for plasmid naming are colored in red. Note that the total 
number of possible loxP distances is 23. 
Size in bp before any 
excision 
Intermediate size in bp if 
Dre excised first 
Intermediate size in bp if 
FRT excised first 
Size in bp after Dre 
and FRT excision 
70 No Dre or FLP sites present 
75 No Dre or FLP sites present 
90 No Dre or FLP sites present 
1045 Only FLP sites present 120 
1075 Only FLP sites present 150 
1125 Only FLP sites present 200 
1325 Only FLP sites present 400 
3359 2183 2026 850 
4075 2899 2742 1566 
4868 3692 3535 2359 
 
Linear plus linear recombineering (Fu et al., 2012) was used to replace the Neo gene with the Bsd gene. 
The recombineering protocol is schematically represented and described in Figure 8. After the completion 
of the protocol, seven Tet-resistant colonies per construct were miniprep-isolated as described in Genetic 
engineering methods. The DNA was digested with PvuII to verify the accuracy of the recombineering 
procedure. Figure 9 depicts the clones that showed the desired digestion pattern and that were further 
verified by DNA sequencing of junctions between the 5'- or 3'-end of the Bsd gene and the surounding TC 
DNA (Eurofins Genomics Sequencing Service). These clones were subsequently used for targeting of the 
mNanog gene. 
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Figure 8. Scheme of the recombineering experiment used to exchange the Neo for the Bsd cassette in 7 out of 10 
plasmids used for mNanog gene targeting. 
Homology arms (HA) present on the primers are homologous to the pNeo-(70-400) sites surrounding the Neo cassette 
and facilitate homolohous recombination. For detailed description of the protocol, refer to Genetic engineering 
methods. 
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Figure 9. PvuII-digested pBsd-(70-2359) after the recombineering experiment.  
The upper picture represents the expected PvuII digestion pattern for all 10 plasmids produced with the Gene 
Construction Kit (Textco Biosoftware). The lower picture represents the experimentally obtained digestion pattern. 
4.3.  5' and 3' Southern probe template production 
Screening of the targeted mESCs by Southern blot often requires two probes to ensure that both ends of the 
TC are faithfully integrated into the mESC genome. To obtain PCR products used for the subsequent 5' and 
3' probe template production, the following primers were used: mNanog 5' probe F, mNanog 5' probe R, 
mNanog 3' probe and mNanog 3' probe R. Taq-based PCR was performed using the wild type E14 mESC 
DNA and the above mentioned primers and the amplification was assessed by agarose electrophoresis. The 
PCR products were purified from the PCR mix. pBlue plasmids from GB05 cells were miniprepped and 
digested with BamHI-HF and EcoRI-HF. The same digest was done with the PCR products to produce the 
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same sticky ends. After agarose electrophoresis and gel extraction, pBlue plasmid and the PCR product 
were ligated using the T4 ligase, electroporated into GB05 cells and plated onto LB plates with IPTG and 
X-gal. White colonies were picked, grown overnight, and miniprepped. The cloned plasmids were digested 
using BamHI-HF and EcoRI-HF to verify the insert size. The majority of the digested cloned plasmids 
showed the expected pattern (Figure 10). After sequencing, 5' clone #4 and 3' clone #13 were chosen for 
further experiments. 
 
Figure 10. BamHI and EcoRI digest of BluescriptKS + 5'/3' mNanog SB probe.  
Expected product sizes are 435 bp for 5' probe and 315 bp for 3' probe. The plasmid backbone yields a 3 kb product. 
4.4.  mNanog targeting and screening 
mNanog gene targeting experiment involved the electroporation of each of the ten circular maxiprepped 
plasmids carrying the TC, namely pBsd-(70-2359) together with pCas9 and pgRNA-mNanog plasmids. The 
sequence of crRNA portion of the sgRNA is TAAGAATGTTTCTACTTAGG. The gene targeting 
mechanism is shown in Figure 11. Figure 12 depicts the smallest TC cassette (Bsd-70) inserted into the 
mNanog background, with the binding site of the 5'-mNanog probe used for Southern blot testing indicated 
within the first intron. The 3'-mNanog probe was not used for the testing (see 4.5) due to low specificity for 
the genomic binding site. 
One day after eletroporation, cells were selected with Bsd and G418. The medium was changed every 
second day, with selection alternating between Bsd + G418, Bsd + Puro and G418 + Puro to avoid loss of 
intergrated genetic elements. Eight days after plating, the resistant colonies reached the satisfactory size 
and were picked and plated into 96-well plates, one colony per well. To ensure that positive colonies are 
encountered, at least 48 colonies were picked per TC. After four days of growing, the colonies were 
expanded into two 96-well plates and further grown for three days. Cells from one plate were frozen and 
cells from the second plate were expanded to a 24-well format and grown until confluency was reached. 
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What followed was a Southern blot protocol with the purpose of testing for correct TC insertion into the 
mNanog gene, described in detail in Methods. The results of the Southern blot-based screen are shown in 
Figure 13 and the summary of all the isolated positive lines is given in Table 21. 
 
Figure 11. Workflow of the mNanog gene targeting experiment. 
R1 13-18 mESCs are co-electroporated with one of the 10 prepared TCs together with gRNA- and Cas9-producing 
plasmids. After the DSB has been induced in the first intron of the mNanog gene by gRNA/Cas9 complex, the TC is 
inserted into the gene by HR. Nucleotides highlighted in blue represent the PAM sequence. The red triangle points to 
the exact location where the DSB occurs on the DNA strand complementary to the shown gRNA. E1-4 labels are 
mNanog exons and the intervening sequences are introns. The protein coding portion of the exons is depicted in black. 
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Figure 12. mNanog-Bsd-70 cassette inserted into the mNanog gene.  
The 5' mNanog probe binding site is highlighted in orange. Ends of TC homology arms are highlighted in purple. 
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Figure 13. Results of the screening for successful mNanog gene targeting events by Southern blot. 
Each picture is labeled with the TC number (eg. 70 + Cas9) in the lower left corner. WT and TC expected band sizes 
are indicated and positive clones are rounded. 
Table 21. Synopsis of the positive clones isolated during the Southern blot screening of targeted 13-18 R1 cells.  
Targeting construct 
(loxP-loxP distance 
in bp) 
Positive samples isolated 
by Southern blot screening 
Targeting construct 
(loxP-loxP distance 
in bp) 
Positive samples isolated by 
Southern blot screening 
70 14, 17, 63 200 60, 61 
75 17, 18, 19, 27 400 15, 16, 20, 23 
90 3, 8, 18 850 7, 9, 13, 20 
120 4, 20, 31 1566 1, 2, 5, 21, 23, 26, 27 
150 11, 41, 43 2359 36, 42, 56, 58, 59, 63, 67, 71, 73 
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4.5.  Further verification of the positive targeting events 
We initially wanted to use both 5'- and 3'-mNanog probe for targeting verification. However, the 3'-mNanog 
probe showed unspecific binding, manifested as a smear on the gel, to E14 mESC DNA digested with either 
EcoRI or AfeI (Figure 14). We thus decided to use a different strategy to test the gene targeting cassette-
mNanog gene 3' junction, ie. PCR-based verification. To this end, we developed the PCR primers 
appropriate for testing the 3' junctions of the three largest constructs (mNanog-Bsd-850, 1566 and 2359). 
The criteria we used during the design are following: a band of correct size should be produced only if the 
TC was correctly inserted; a band should not be produced if the sample is WT, if the TC was inserted at the 
wrong locus or if it was partially inserted, leaving out the 3' end; the primers should be able to later be used 
for sequencing of the 3' junctions (the product length thus needs to be considerable, ideally above 500 bp). 
For 850 and 1566 constructs, we obtained the primers named 850/1566 F and R with the expected product 
size being 698 bp. For 2359 construct, we obtained the primers named 2359 F and R with the expected 
product size being 815 bp. Results of the primer testing are shown in the Figure 15. 
 
Figure 14. Testing of the 3'-mNanog probe on E14 mESC WT DNA digested with EcoRI and AfeI. 
The expected product sizes are 7719 bp for EcoRI and 9507 bp for AfeI.  
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Figure 15. Testing of primers for TC-mNanog gene3' junction verification.  
Lane 1: negative control (no DNA added, both primer pairs added); lane 2: negative control (''WT'' R1 13-18 DNA 
tested, both primer pairs added); lane 3: positive control (circular pBsd-1566 plasmid tested with 850/1566 primers); 
lane 4: positive control (circular pBsd-2359 plasmid tested with 2359 primers); lane 5: positive targeting event of 
pBsd-850 TC into R1 13-18 mESCs tested on clone #13 with 850/1566 primers; lane 6: positive targeting event of 
pBsd-1566 TC into R1 13-18 mESCs tested on clone #21 with 850/1566 primers). Expected product sizes: 698 bp for 
lane 3, 5 and 6; 815 bp for lane 4. 
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5. DISCUSSION 
DNA double helix is surprisingly resistant to twisting and bending in comparison to other biopolymers. It 
is of great interest to elucidate the mechanisms responsible for DNA's remarkable ability to loop and 
condense and connect these mechanisms with its biological roles. Major advancements have been made in 
this particular field of biophysics when it comes to DNA flexibility in vitro. However, much remains to be 
discovered regarding the observed changes of DNA flexibility in different in vivo contexts. For example, 
mechanisms involved in possible changes of DNA flexibility in vivo upon heterochromatinization have not 
been comprehensively studied yet. Acquiring knowledge of these concepts will contribute to our 
understanding of gene expression regulation during development, in physiological contexts as well as 
desease and it will facilitate improvements in genetic engineering and bionanotechnology. To 
experimentally test the differences in DNA flexibility upon heterochromatinization we have decided to 
employ a method of DNA flexibility measurement based on the site-specific recombination and quantitative 
Southern blot, previously developed by Ringrose et al.,1999. The aim of this thesis was to produce the 
mouse embryonic stem cell clones containing the site specific recombination sites (loxP) of various 
distances which will be used for purposes of the aforementioned DNA flexibility comparison. 
In this project we have successfully tested the mouse embryonic stem cell Cre reporter line for CreERT2-
inducibility, prepared the plasmids containing the targeting construct for mNanog gene targeting, produced 
the 5'- and 3'-mNanog probe template for Southern blotting, targeted the mentioned cell line with 10 
targeting constructs, isolated positive clones for all of them by Southern blotting and developed a PCR-
based strategy for further verification of positive clones.  
We have managed to develop all 10 desired mESC cell lines achieving frequency of the successfully 
targeted events of 13.3 %. This frequency is strikingly similar to the one previously reported by our group 
in Baker et al., 2017, which amounted to 14 %. The authors used the same principle of CRISPR-Cas9-
assisted gene targeting, although their TCs significantly differed from ours in size. The aim of their 
experiment was to humanize the 39.5 kb long mouse Kmt2d gene. Their TCs contained a 4 kb 5'-HA (our 
5'-HA is 2.14 kb long) and an extremely long 3' HA, the length of which is 42 kb (compared to our 4.52 kb 
long 3' HA). The length of our largest TC without homology arms is 4.9 kb, which is roughly 10 times less 
than the size of the mouse Kmt2d gene. The conclusion we draw from this is that TCs of vastly different 
sizes can be targeted with similar frequencies provided that homology arm lengths are adjusted according 
to the TC body size. Taking this into consideration, it is interesting to notice that we did not observe any 
reduction in the targeting efficiency when comparing our longest and shortest constructs, although the 
lengths of homology arms were held constant. On the contrary, our longest constructs Bsd-1566 and -2359 
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integrated with the highest frequency. This might however not reflect true differences in targeting 
efficiencies among our constructs of different sizes, but rather improvements in the Southern blot method 
we implemented during the screening procedure (the longest constructs were screened the last). In light of 
this, we suspect that the true frequency of our targeting exercise might be higher due to some putative false 
negatives caused by inconsistent quality of Southern blot results. 
There are various ways the Southern blot protocol could be improved. For example, the amount of genomic 
DNA could be higher. For our purposes this was difficult to achieve because it would include further 
expansion of targeted clones into 6-well plates, which would be highly time consuming. Moreover, the 
DNA isolation could be enhanced. We have already investigated this possibility by replacing the invert-
and-spill method used while precipitating the DNA with ethanol and sodium chloride with the manual one-
by-one aspiration of the mixture, without significant increases in DNA yields. We have also tried replacing 
sodium chloride with ammonium acetate with similar results. The parameter we concluded was critical 
during the Southern blot testing is the amount of the probe template used. Not only was it possible to use 
the amount that is too low, but it also seemed that higher concentrations of the probe template inhibit the 
radioactive probe synthesis. It is therefore crucial to finetune the amount of the template used. Running a 
gel overnight at lower voltage (eg. 30 V) might have been helpful in obtaining clearer, more compact bands. 
The transfer of the DNA to the nylon membrane could be enhanced by taping the ends of the gel with 
parafilm to avoid the water bridge formation. Furthermore, it might be worth trying to omit washing the 
membrane in 6x SSC after the transfer, which could help to avoid washing off the DNA before fixing it by 
UV-irradiation and baking. A standard way to improve the Southern blot efficiency is by decreasing the 
hybridization or CG-wash temperature, albeit at the risk of introducing higher background. We have also 
tried modifying these temperatures without much success. Furthermore, we have tested longer development 
time, for example over the weekend instead of over night, with moderate increases in yields. It is worth 
noting that our 1 kb ladders were consistently producing bands of reasonable intensity, so the problem does 
not seem to stem from the transfer or the post-transfer steps but the amount of preparation of the genomic 
DNA. 
Another commonly used method for gene targeting screens is the qPCR. We have avoided employing this 
method due to difficulties in designing the primers which would unequivocally distinguish between true 
positive events and all other possible scenarios. 
Finishing the screening procedure would require testing the 3' TC-mNanog junction of all of the positive 
clones either by Southern blot, which would include the development of the new, more specific 3'-mNanog 
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probe template, or by PCR and sequencing. Based on the results we presented, it seems that the PCR-based 
screening is a satisfying strategy for colonies that are previously confirmed as positive by Southern blot. 
Figure 15 shows a preliminary test which requires additional controls and samples. For negative controls, 
the primer pairs need to be tested separately and not added simultaneously to better reflect the conditions 
under which positive controls and targeted samples were tested. One of the positive controls is missing, ie. 
the 850 plasmid sample, due to the lack of the miniprep sample at the time of testing. Also, one of the 
positive 2359 + Cas9 clones should have been included in the test but this was not possible as the test was 
performed before the first positive 2359 + Cas9 clones were obtained. 
Future work on this project will include the verification of positive colonies either by PCR or by using a 
functioning 3'-mNanog probe, 4-OHT-induced loxP excision test and preparation of a larger variety of loxP 
distances by Dre/rox and FLP/FRT recombination on the existing positive clones, optimization and 
measurement of DNA flexibility in mESCs based on the relative quantitative Southern blot assay and 
comparison with the previously published results (Ringrose et al., 1999), mESC differentiation into NSCs 
and their DNA flexibility measurement, and finally, comparison of dependence of DNA flexibility on 
mNanog gene compaction that occurs during differentiation into NSCs. 
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6. CONCLUSIONS 
1) Ten different gene targeting constructs containing the Bsd gene and loxP sites of different distances 
were prepared by recombineering and verified by restriction digestion and sequencing. 
2) Templates for 5'- and 3'- Southern blot probes were prepared by gene cloning and verified by PCR. 
3'-probe needs to be redesigned due to low specificity for the target genomic site. 
3) mNanog targeting in the mouse embryonic stem cells was successful and positive colonies were 
found by Southern blot using the 5'-probe. The efficiency of targeting was 13.3 %. The Southern 
blot screening procedure needs further optimization so that false negative results can be avoided. 
4) A PCR strategy for the validation of the 3' targeting construct-mNanog junction was successfully 
developed and tested and can be used in further experiments as a substitute for the Southern testing 
with the 3'-mNanog probe. 
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8. CURRICULUM VITAE 
IVAN MIKIČIĆ 
1. EDUCATION 
Master's program in Molecular Biology 
-University of Zagreb, Faculty of Science | September 2015 – February 2018 
• Erasmus+ exchange year (study visit and internship) 
-Technische Universität Dresden, BIOTEC | October 2016 – October 2017 
Bachelor's program in Molecular Biology 
-University of Zagreb, Faculty of Science | October 2012 – September 2015 
IV. Gymnasium in Zagreb 
-Bilingual Croatian-English program | September 2008 – July 2012 
 
2. PERSONAL SKILLS 
A) Language skills 
• Croatian – native proficiency 
• English – proficiency (Cambridge Certificate in Advanced English, 2012, level C2) 
• German – advanced (TU Dresden German course, 2017, level C1/C2; Summer German course at the Ludwig-
Maximilian University in Munich, 2015, level B2) 
B) Laboratory skills 
Southern blotting, mammalian cell culture (mouse embryonic stem cells, MEF feeder cells and U2OS cells), PCR, 
bacterial cell culture, genetic engineering techniques, Western blot, CRISPR-Cas9, Immunoprecipitation, 
fluorescence and bright-field microscopy 
C) Computer skills 
• Good command of Microsoft Office tools 
• Good command of basic bioinformatics tools (databases, genome browsers, sequence alignment, homology 
search, phylogenetic trees, molecular graphics) 
• Picture Editing Software 
• Plasmid Mapping Software (eg. SnapGene) 
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D) Organizational/communication skills 
• Leader of Section for Bioinformatics at Biology Students Association (2016) 
• Organization of the Night of Biology at the University of Zagreb (2016, 2014) 
• Organization of the Open Day of the Division of Chemistry at the University of Zagreb (2015) 
 
3. ADDITIONAL INFORMATION 
A) Theses 
• Master's thesis: Establishment of recombinant mouse embryonic stem cells for use in DNA flexibility 
assays | Mentors: Dr. Francis Stewart and Dr. Ivana Ivančić Baće | February 2018 
• Bachelor's thesis: Experimental Methods in Functional Genomics | Mentor: Kristian Vlahoviček | September 
2015 
B) Jobs 
• Testing of programs for secondary analysis of next generation sequencing reads | Employer: Slobodan 
Obrenović (freelance programmer) | February – June 2016, Zagreb 
C) Summer schools 
• International Summer School at the Institute of Molecular Biology, Mainz, Germany | Phosphoproteomics - 
Cellular response to UV light-induced DNA damage | Mentor: Petra Beli | August – September 2016  
• Summer Undergraduate Research Programme at the University of Lausanne, Switzerland | Research topic: 
Plant developmental genetics | Mentor: Christian Hardtke | July – August 2014 
D) Internships 
• Translational Medicine lab, Ruđer Bošković Institute, Zagreb | Gateway Cloning for establishment of 
plasmids for high-throughput protein-protein interaction screens | Mentor: Oliver Vugrek | October 2015 – 
February 2016 
• Microbiology lab, University of Zagreb | Research topic: Bacterial and viral plant pathogen genetics | Mentor: 
Martina Šeruga Musić | February – June 2015 
E) Honors and awards 
• Student scholarship awarded by the City of Zagreb | Academic year 2016/2017 and 2015/2016 
• Student scholarship awarded by the University of Zagreb | Academic year 2014/2015 
• Special award ''Mitko Naumovski'' for academic excellence by Rotary Club Zagreb Center | 2014 
• Scholarship for excellence ''Gordan Čačić'' by Rotary Club Zagreb Center | 2011 – 2014 
